CD200 and neoplasm: When we examined CD8+ cells in DLN of tumor-bearing CD200-/- mice (Fig 5C), we found that metformin increased the numbers of CD8+ cells in DLN regardless of growth of control EMT6 or EMT6siCD200 tumors.